News for Healthier Living

Survivors of High-Risk Neuroblastoma Face Substantial Late Effects of Modern Therapies

Within the last two decades, multiple stem cell transplants and immunotherapy were added to intensive chemotherapy as the standard of care for high-risk neuroblastoma, drastically improving survival of this childhood cancer.

October 20, 2025


October 21 2025

October 20 2025

October 19 2025

October 18 2025

October 17 2025

October 16 2025

October 15 2025

October 14 2025

October 13 2025

October 12 2025

October 11 2025

October 10 2025

October 9 2025

October 8 2025

October 7 2025